BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19784847)

  • 1. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
    Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
    Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
    BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing prognostic factors in osteosarcoma: analysis of 381 cases from two institutions.
    Xing D; Qasem SA; Owusu K; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2014 Aug; 45(8):1688-96. PubMed ID: 24931466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
    Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
    Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.
    Bispo Júnior RZ; Camargo OP
    Clinics (Sao Paulo); 2009; 64(12):1177-86. PubMed ID: 20037705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
    Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
    Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
    Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
    Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival rate of osteosarcoma: A single-institution study.
    Faisham WI; Mat Saad AZ; Alsaigh LN; Nor Azman MZ; Kamarul Imran M; Biswal BM; Bhavaraju VM; Salzihan MS; Hasnan J; Ezane AM; Ariffin N; Norsarwany M; Ziyadi MG; Wan Azman WS; Halim AS; Zulmi W
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e104-e110. PubMed ID: 25870979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.
    Pruksakorn D; Phanphaisarn A; Arpornchayanon O; Uttamo N; Leerapun T; Settakorn J
    Cancer Epidemiol; 2015 Dec; 39(6):956-63. PubMed ID: 26540607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma.
    Yang Q; Chen T; Yao Z; Zhang X
    World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
    Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
    J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
    Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution.
    Wang W; Yang J; Wang Y; Wang D; Han G; Jia J; Xu M; Bi W
    Pathol Res Pract; 2017 Feb; 213(2):119-125. PubMed ID: 28040328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.